1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 8th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Autonomic dysfunction in post-COVID patients with & witfhout neurological symptoms: a prospective multidomain observational study, 2021, Stella et al

Discussion in 'Long Covid research' started by Andy, Aug 14, 2021.

  1. Andy

    Andy Committee Member

    Messages:
    21,914
    Location:
    Hampshire, UK
    Abstract

    The autonomic nervous system (ANS) can be affected by COVID-19, and dysautonomia may be a possible complication in post-COVID individuals. Orthostatic hypotension (OH) and postural tachycardia syndrome (POTS) have been suggested to be common after SARS-CoV-2 infection, but other components of ANS function may be also impaired. The Composite Autonomic Symptom Scale 31 (COMPASS-31) questionnaire is a simple and validated tool to assess dysautonomic symptoms. The aim of the present study was to administer the COMPASS-31 questionnaire to a sample of post-COVID patients with and without neurological complaints. Participants were recruited among the post-COVID ambulatory services for follow-up evaluation between 4 weeks and 9 months from COVID-19 symptoms onset. Participants were asked to complete the COMPASS-31 questionnaire referring to the period after COVID-19 disease. Heart rate and blood pressure were manually taken during an active stand test for OH and POTS diagnosis. One-hundred and eighty participants were included in the analysis (70.6% females, 51 ± 13 years), and OH was found in 13.8% of the subjects. Median COMPASS-31 score was 17.6 (6.9–31.4), with the most affected domains being orthostatic intolerance, sudomotor, gastrointestinal and pupillomotor dysfunction. A higher COMPASS-31 score was found in those with neurological symptoms (p < 0.01), due to more severe orthostatic intolerance symptoms (p < 0.01), although gastrointestinal (p < 0.01), urinary (p < 0.01), and pupillomotor (p < 0.01) domains were more represented in the non-neurological symptoms group. This study confirms the importance of monitoring ANS symptoms as a possible complication of COVID-19 disease that may persist in the post-acute period.

    Open access, https://link.springer.com/article/10.1007/s00415-021-10735-y
     
    spinoza577, sebaaa, DokaGirl and 4 others like this.
  2. MeSci

    MeSci Senior Member (Voting Rights)

    Messages:
    4,492
    Location:
    Cornwall, UK
    Hi, @Andy - you've included an extra 'f' in the title 'Autonomic dysfunction in post-COVID patients with & witfhout...'
     
    DokaGirl likes this.
  3. Andy

    Andy Committee Member

    Messages:
    21,914
    Location:
    Hampshire, UK
    That's how it currently is on the journal's website....
     
    DokaGirl, Hutan, Graham and 4 others like this.
  4. rvallee

    rvallee Senior Member (Voting Rights)

    Messages:
    12,425
    Location:
    Canada
    Editorial and review process? What editorial and review process?
     
    DokaGirl and alktipping like this.
  5. DokaGirl

    DokaGirl Senior Member (Voting Rights)

    Messages:
    3,664
    I kind of like that new word: "witfhout"....

    But, more seriously, perhaps findings in autonomic dysfunction in pwLHCOVID may lead somewhere.

    Several years pre ME I had a nasty flu for about 7 to 10 days that made me feel quite faint when upright. I suppose this flu symptom is fairly common. Fortunately, back then, post flu, the OI went away. Really wish it would go away now. :(
     
    Simbindi, MeSci, Trish and 1 other person like this.
  6. chrisb

    chrisb Senior Member (Voting Rights)

    Messages:
    4,602
    Perhaps its an old English "s", which would make the word "witshout", which everyone knows is Shakespearean for a loud joke.
     

Share This Page